Deoxynivalenol transport across the human placental barrier

Food and Chemical Toxicology

Volumn 49, Issue 9, 2011, Pages 2046-2052

  Nielsen, Jeanette K S ^a   Vikström, Anna C ^a   Turner, Paul ^b,c   Knudsen, Lisbeth E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

BeWo; Deoxynivalenol; Foetal exposure; In vitro modelling; Perfusion; Placental transfer

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; VOMITOXIN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PLACENTA BARRIER; CELL CLONE; CELL FUNCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PLACENTA PERFUSION; PLACENTAL TRANSFER; TISSUE LEVEL; TRANSCYTOSIS; TROPHOBLAST;

CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; MYCOTOXINS; PLACENTA; PREGNANCY; TRICHOTHECENES;

ANIMALIA;

EID: 79960843090     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.05.016     Document Type: Article

References (53)

1. Abdulrazzaq Y.M., Osman N., Ibrahim A. Fetal exposure to aflatoxins in the United Arab Emirates. Annals of Tropical Paediatrics 2002, 22:3-9.
2. Bhat R.V., Beedu S.R., Ramakrishna Y., Munshi K.L. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet 1989, 1:35-37.
3. Bode C.J., Jin H., Rytting E., Silverstein P.S., Young A.M., Audus K.L. In vitro models for studying trophoblast transcellular transport. Methods in Molecular Medicine 2006, 122:225-239.
4. Collins T.F., Sprando R.L., Black T.N., Olejnik N., Eppley R.M., Hines F.A., Rorie J., Ruggles D.I. Effects of deoxynivalenol (DON, vomitoxin) on in utero development in rats. Food and Chemical Toxicology 2006, 44:747-757.
5. Correia Carreira S., Cartwright L., Mathiesen L., Knudsen L.E., Saunders M. Studying placental transfer of highly purified non-dioxin-like PCBs in two models of the placental barrier. Placenta 2011, 32:283-291.
6. Council and Task (2003) (Counsil of Agricultural Science and Technology). Potential economic cost of mycotoxins in the United States. Mycotoxins: risks in plant, animal and human systems. In: Task force report No.139, Ames, IA, USA, pp. 136-142.
7. Denning D.W., Allen R., Wilkinson A.P., Morgan M.R. Transplacental transfer of aflatoxin in humans. Carcinogenesis 1990, 11:1033-1035.
8. Ehrlich K.C., Daigle K.W. Protein synthesis inhibition by 8-oxo-12,13-epoxytrichothecenes. Biochimica et Biophysica Acta 1987, 923:206-213.
9. Enders A.C., Carter A.M. What can comparative studies of placental structure tell us? - a review. Placenta 2004, 25:S3-S9.
10. Etzel R.A. Mycotoxins. JAMA 2002, 287:425-427.
11. Evseenko D.A., Paxton J.W., Keelan J.A. ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2006, 290:R1357-R1365.
12. Frederiksen M., Vorkamp K., Mathiesen L., Mose T., Knudsen L.E. Placental transfer of the polybrominated diphenyl ethers BDE-47, BDE-99 and BDE-209 in a human placenta perfusion system: an experimental study. Environmental Health 2010, 9:32.
13. Garon D., Richard E., Sage L., Bouchart V., Pottier D., Lebailly P. Mycoflora and multimycotoxin detection in corn silage: experimental study. Journal of Agricultural and Food Chemistry 2006, 54:3479-3484.
14. Goyarts T., Danicke S., Brussow K.P., Valenta H., Ueberschar K.H., Tiemann U. On the transfer of the Fusarium toxins deoxynivalenol (DON) and zearalenone (ZON) from sows to their fetuses during days 35-70 of gestation. Toxicology Letters 2007, 171:38-49.
15. Hepworth S.J., Hardie L.J., Fraser L.K., Burley V.J., Miljal R.S., Wild C.P., Azad R., McKinney P.A., Turner P.C. Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK. Food Additives & Contamination Part A Chemistry Analysis Control Exposure & Risk Assessment 2011, 1:1-8.
16. Jackson L.S., Bullerman L.B. Effect of processing on Fusarium mycotoxins. Advances in Experimental Medicine and Biology 1999, 459:243-261.
17. Kristensen P., Irgens L.M., Andersen A., Bye A.S., Sundheim L. Gestational age, birth weight, and perinatal death among births to Norwegian farmers, 1967-1991. American Journal of Epidemiology 1997, 146:329-338.
18. Luo X.Y. Outbreaks of moldy cereal poisonings in China. Toxicology Forum and the Chinese Academy of Preventive Medicine: Issues in Food Safety 1988, Toxicology Forum, Washington, DC, pp. 56-63.
19. Mathiesen L., Rytting E., Mose T., Knudsen L.E. Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: effect of albumin in the perfusion medium. Basic & Clinical Pharmacology & Toxicology 2009, 105:181-187.
20. Mathiesen L., Mose T., Morck T.J., Nielsen J.K., Nielsen L.K., Maroun L.L., Dziegiel M.H., Larsen L.G., Knudsen L.E. Quality assessment of a placental perfusion protocol. Reproductive Toxicology 2010, 30:138-146.
21. Meky F.A., Turner P.C., Ashcroft A.E., Miller J.D., Qiao Y.L., Roth M.J., Wild C.P. Development of a urinary biomarker of human exposure to deoxynivalenol. Food and Chemical Toxicology 2003, 41:265-273.
22. Morck T.J., Sorda G., Bechi N., Rasmussen B.S., Nielsen J.B., Ietta F., Rytting E., Mathiesen L., Paulesu L., Knudsen L.E. Placental transport and in vitro effects of Bisphenol A. Reproductive Toxicology 2010.
23. Mose T., Mortensen G.K., Hedegaard M., Knudsen L.E. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reproductive Toxicology 2007, 23:83-91.
24. Mose T., Kjaerstad M.B., Mathiesen L., Nielsen J.B., Edelfors S., Knudsen L.E. Placental passage of benzoic acid, caffeine, and glyphosate in an ex vivo human perfusion system. Journal of Toxicology and Environmental Health. Part A 2008, 71:984-991.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
26. Myllynen P., Kummu M., Kangas T., Ilves M., Immonen E., Rysa J., Pirila R., Lastumaki A., Vahakangas K.H. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicology and Applied Pharmacology 2008, 232:210-217.
27. Partanen H.A., El-Nezami H.S., Leppanen J.M., Myllynen P.K., Woodhouse H.J., Vahakangas K.H. Aflatoxin B1 transfer and metabolism in human placenta. Toxicological Sciences 2010, 113:216-225.
28. Pestka J.J. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Archives of Toxicology 2010, 84:663-679.
29. Pestka J.J., Smolinski A.T. Deoxynivalenol: toxicology and potential effects on humans. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 2005, 8:39-69.
30. Pestka J.J., Islam Z., Amuzie C.J. Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse. Toxicology Letters 2008, 178:83-87.
31. Poulsen M.S., Rytting E., Mose T., Knudsen L.E. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicology in Vitro 2009, 23:1380-1386.
32. Prelusky D.B., Veira D.M., Trenholm H.L. Plasma pharmacokinetics of the mycotoxin deoxynivalenol following oral and intravenous administration to sheep. Journal of Environmental Science and Health. Part B: Pesticides, Food Contaminants, and Agricultural Wastes 1985, 20:603-624.
33. Prelusky D.B., Hartin K.E., Trenholm H.L., Miller J.D. Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fundamental and Applied Toxicology 1988, 10:276-286.
34. Rama S., Petrusz P., Rao A.J. Hormonal regulation of human trophoblast differentiation: a possible role for 17beta-estradiol and GnRH. Molecular and Cellular Endocrinology 2004, 218:79-94.
35. Rotter B.A., Oh Y.N. Mycotoxin fumonisin B1 stimulates nitric oxide production in a murine macrophage cell line. Natural Toxins 1996, 4:291-294.
36. SCF. (2002) (Scientific Committee on Food) Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol. In: http://ec.europa.eu/food/fs/sc/scf/out123_en.pdf.
37. Schlatter J. Toxicity data relevant for hazard characterization. Toxicology Letters 2004, 153:83-89.
38. Schneider H., Panigel M., Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. American Journal of Obstetrics and Gynecology 1972, 114:822-828.
39. SCOOP. (2003) (Scientific Cooperation). Collection of Occurrence Data of Fusarium toxins in Food and Assessment of Dietary Intake by the Population of EU Member States. In: SCOOP TASK 3.2.10 Final Report, http://ec.europa.eu/food/fs/scoop/task3210.pdf.
40. Sergent T., Parys M., Garsou S., Pussemier L., Schneider Y.J., Larondelle Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicology Letters 2006, 164:167-176.
41. Tiemann U., Brussow K.P., Danicke S., Vanselow J. Feeding of pregnant sows with mycotoxin-contaminated diets and their non-effect on foetal and maternal hepatic transcription of genes of the insulin-like growth factor system. Food Additives and Contaminants 2008, 1-9.
42. Tiemann U., Brussow K.P., Dannenberger D., Jonas L., Pohland R., Jager K., Danicke S., Hagemann E. The effect of feeding a diet naturally contaminated with deoxynivalenol (DON) and zearalenone (ZON) on the spleen and liver of sow and fetus from day 35 to 70 of gestation. Toxicology Letters 2008, 179:113-117.
43. Turner P.C., Collinson A.C., Cheung Y.B., Gong Y., Hall A.J., Prentice A.M., Wild C.P. Aflatoxin exposure in utero causes growth faltering in Gambian infants. International Journal of Epidemiology 2007, 36:1119-1125.
44. Turner P.C., Burley V.J., Rothwell J.A., White K.L., Cade J.E., Wild C.P. Deoxynivalenol: rationale for development and application of a urinary biomarker. Food Additives & Contaminants. Part A Chemistry Analysis Control Exposure & Risk Assessment 2008, 25:864-871.
45. Turner P.C., Burley V.J., Rothwell J.A., White K.L., Cade J.E., Wild C.P. Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. Journal of Exposure Science & Environmental Epidemiology 2008, 18:392-399.
46. Turner P.C., Rothwell J.A., White K.L., Gong Y., Cade J.E., Wild C.P. Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom. Environmental Health Perspectives 2008, 116:21-25.
47. Turner P.C., Taylor E.F., White K.L., Cade J.E., Wild C.P. A comparison of 24h urinary deoxynivalenol with recent v. average cereal consumption for UK adults. The British Journal of Nutrition 2009, 102:1276-1279.
48. Turner P.C., Hopton R.P., Lecluse Y., White K.L., Fisher J., Lebailly P. Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. Journal of Agricultural and Food Chemistry 2010, 58:5206-5212.
49. Turner P.C., White K.L., Burley V.J., Hopton R.P., Rajendram A., Fisher J., Cade J.E., Wild C.P. A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults. Biomarkers 2010, 15:553-562.
50. Turner P.C. Deoxynivalenol and nivalenol occurrence and exposure assessment. World Mycotoxin Journal 2010, 315:321.
51. Turner P.C., Hopton R.P., White K.L., Fisher J., Cade J.E., Wild C.P. Assessment of deoxynivalenol metabolite profiles in UK adults. Food and Chemical Toxicology 2011, 49:132-135.
52. Videmann B., Tep J., Cavret S., Lecoeur S. Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food and Chemical Toxicology 2007, 45:1938-1947.
53. WR M.M. Outbreaks of Gastrointestinal Illness of Unknown Etiology Associated With Eating Burritos ÇöUnited States, October 1997-October 1998. JAMA: The Journal of the American Medical Association 1999, 281:1263-1264.